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Freezing of gait (FOG) is a common, disabling gait disturbance in Parkinson’s disease
(PD) and other Parkinsonian syndromes. Freezing also occurs during non-gait movements involving the upper limbs. The mechanisms underlying freezing are complex,
likely involving motor, cognitive, and sensory systems that contribute to the episodes.
Here, we reported a 60-year-old female with a 24-year history of parkinsonism who
experienced significant FOG when ambulatory. Disease progression resulted in her
permanent use of a powered wheelchair. While using the power chair, the patient experiences apparent paroxysmal freezing in the hand and arm used to steer and propel the
chair. These episodes, some lasting up to several minutes, occur only in circumstances
(e.g., entering and leaving an elevator) that are similar to environments known to elicit
and exacerbate FOG. Episodes are transient and can be volitionally interrupted by the
patient but sometimes require external assistance. Therapeutic intervention for this type
of potential freezing has yet to be determined. This case may provide insight into the
complex nature of freezing behavior and suggests a need for new approaches to treating
non-traditional freezing behavior.
Keywords: Parkinson’s disease, hypokinesia, upper-limb freezing, freezing, akinesia

INTRODUCTION
Freezing of gait (FOG) is a common and disabling motor symptom of Parkinson’s disease (PD)
and other Parkinsonian conditions. FOG is defined as a “brief, episodic absence or marked reduction of forward progression of the feet despite the intention to walk” (1). Approximately half of
people with PD will experience FOG as the disease progresses (2). While it is typically associated
with greater disease duration and dose of levodopa medication, FOG can affect some individuals
earlier in the disease course (3). The health-related impact of FOG is concerning. FOG is associated
with an increased risk of falling (4, 5), reduced quality of life (6), and cognitive impairment (7, 8).
While pharmacologic and surgical treatment can alleviate freezing episodes in some patients, others
continue to exhibit freezing behavior despite optimal treatment with these therapies (9, 10). These
observations suggest that FOG may involve non-dopaminergic systems (3), but the causal pathways
remain poorly understood.
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While freezing predominantly affects walking and stepping,
recent work showed that freezing can affect non-gait motor
systems as well (11). These data indicate that similar freezing
can occur during upper-limb and finger movements (12–14),
as well as during speech (15). While gait and non-gait freezing
do not necessarily co-occur, these data suggest that some common mechanism underlies motor arrests in PD. As such, in the
remainder of this case report, we will use the term “freezing” to
include both gait and non-gait phenomena.
Various hypotheses describing potential mechanisms of freezing have been proposed, including impaired automaticity (16),
perceptual impairments (17), and cognitive-motor decoupling
(18), and this remains an active area of research. Furthermore,
non-dopaminergic systems such as serotonergic neurons in the
raphe nucleus and cholinergic neurons in the pedunculopontine
nucleus may also play a role (3). Thus, freezing likely involves
a widespread network of various brain regions. In this case
report, we describe a patient with dopa-responsive parkinsonism
who experienced gait freezing when ambulatory and currently
experiences apparent freezing only when operating her powered
wheelchair in situations that often elicit gait freezing. The purpose
of this case is to present a novel task-specific case of potential
freezing and to summarize and expand on the potential neurological mechanisms of freezing.

of carbidopa/levodopa (Unified Parkinson’s Disease Rating
Scale motor subsection (UPDRS III) score improved from 38 to
15.5 with titration). Over the next several years, she developed
motor fluctuations with painful OFF-state left arm/leg dystonia
and peak-dose cervical dystonia (worse on the left). Trials with
ropinerole provided initial relief of OFF-state dystonia, but in late
2001, she developed dose-limiting peak-dose dyskinesia and was
unable to tolerate ropinerole or trials with pergolide, pramipexole,
tolcapone, or entacapone in addition to amantadine and levodopa. Over the next 3 years, she experienced worsening gait (due
in part to worsening left leg dystonia) with freezing that resulted
in at least 2 falls per week by 2004. In 2006, on examination,
gait impairment was characterized independent of dystonia by
inability to lift her feet, particularly on the left side, resembling
the akinetic subtype of FOG (19). At this time, FOG was severe
enough that she used a wheelchair when outside of the home for
safety.
In June 2006, she underwent successful implantation of bilateral subthalamic nucleus deep brain stimulation after OFF/ON
evaluation revealed improvement of the UPDRS III score from
69 in the practically defined OFF state to 13.5 following ingestion
of 600 mg levodopa. DBS resulted in markedly reduced rigidity and tremor, and relieved pain secondary to left arm and leg
dystonia which allowed reduction of levodopa dosing over 50%
during the first year. After DBS, the patient’s gait and mobility
improved substantially, and she did not regularly use her power
scooter. Three years following DBS, she required dose titrations
and again developed motor fluctuations with worsening rest
tremor, dystonia, and FOG. By July of 2009, she was still able to
walk, but again preferred to use a power chair due to fear of falls
in the context of worsening FOG. She was bound to her power
chair in 2012 due to progression of gait instability and FOG with
increased motor fluctuations.
In April 2015, the patient first reported intermittent right
hand freezing while controlling her power wheelchair in specific
situations. Three months later, this apparent freezing of the
upper extremity began to interfere substantially with her ability
to propel her power wheelchair, particularly when entering an
elevator or passing through doorways. The apparent freezing
was mostly in her fingers, which controlled the movement of
her chair. During episodes, the patient does not display dystonic
posturing of the wrist or hand typical of her OFF-period dystonia,
or as an overflow phenomenon. As reported in May of 2016, the
navigation-related upper-limb freezing episodes occur a few
times per day. The suspected freezes observed in the clinic usually
lasted just a few seconds, but the patient reports episodes may last
for as long as 1–10 min. The patient is typically able to break the
motor arrests using her other hand (left) to release fingers of the
right hand from the steering knob. In cases where the episodes
last several minutes, staff members at her living facility intervene
to help break the motor arrest. These apparent freezing episodes
occur when moving the wheelchair both forward and backward.
Entering and exiting elevators are the most common triggers,
though navigating around the dining room in the presence of
other residents who make her feel nervous occasionally triggers
these episodes of potential freezing. The patient reports that these

CASE REPORT
The patient is a 60-year-old woman with a 24-year history of
parkinsonism currently residing in an assisted living facility. She
initially presented to our movement disorder clinic in 1996 with a
4-year history of gradually progressive lower extremity pain and
spasms, and blepharospasm following constipation and urinary
urge. Baclofen and botulinum toxin targeting ocular muscles
provided modest benefit for spasms. The differential remained
broad and initial workup included normal brain magnetic
resonance imaging (MRI), cervical, thoracic, and lumbar spine
MRI, cerebrospinal fluid studies (cell count, protein, glucose,
oligoclonal bands, Lyme titers), complete blood cell count, comprehensive metabolic panel, thyroid-stimulating hormone level,
triiodothyronine (T3) levels, free thyroxine (T4) levels, serum
immunofixation, ceruloplasmin, B12, Venereal Disease Research
Laboratory, erythrocyte sedimentation rate, extractable nuclear
antigen, antinuclear antibody (slightly elevated, but rheumatology
follow-up revealed no association with clinical syndrome), vitamin E, human immunodeficiency virus, human T-cell lymphotropic virus, very long chain fatty acids, electromyography/nerve
conduction studies, serum and urine amino acids, conjunctival
biopsy for lipofuscinosis, urine samples for arylsulfatase A, negative gene testing for spinocerebellar ataxia-type 3, and Huntington
disease.
Over the next 2 years, she displayed progressive asymmetric
(left more than right) leg and arm dystonia with concomitant
development of asymmetric leg then arm rest tremor, rigidity,
and impaired gait (asymmetric foot dragging) and balance. PD
was diagnosed in 1998 following exquisite improvement of rest
tremor, rigidity, dystonia, gait, and blepharospasm with initiation
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navigation-related upper-limb freezing episodes are similar to
gait freezing she experienced previously and are accompanied
by similar sensations and feelings of panic without other panic
attack features. These episodes can occur either at peak dose or in
the off state, but are more frequent and last longer in the off state.
Because the patient is no longer ambulatory, we cannot determine
if she still experiences gait freezing. The patient does not report
this potential upper-limb freezing during any other upper-limb
tasks nor does the apparent upper-limb freezing occur during
wheelchair steering in other circumstances, such as navigating
a wide open space. This is consistent with observations in our
clinic.
On examination, she had saccadic intrusions on smooth
pursuit, but no additional extraocular movement abnormalities.
Finger tapping, hand movement, and leg agility were slow with
diminished amplitude in the OFF more than ON state, but movement always remained visible, except at the moments described
when operating her chair. Bradykinesia remained fairly constant
in the OFF state, whereas the apparent freezing phenomenon was
transient, most often lasting about 5–15 s (though occasionally
longer). There was no increase or change in dystonic posturing when she attempted to initiate hand movements to control
the wheelchair, and she lacked subjective pain that frequently
accompanied OFF-period dystonia. She was otherwise able to
accurately maneuver the wheelchair throughout most of the day,
despite obvious and painful hand dystonia. She denied subjective
concerns of not knowing how to make the desired movement
during freezing episodes, and she lacked constructional or
ideomotor apraxia on formal testing. Freezing episodes did not
depend on whether observers were present or on any apparent
psychological rewards.
She has an extensive psychiatric history including the following symptoms: major depression, hallucinations, and suicidal
ideation. Psychiatric treatments have included thiothixene,
quetiapine, and electroconvulsive therapy with good benefit.
Antipsychotics were last prescribed 10–15 years prior to her first
visit at our center (except for 1–3 nightly doses of quetiapine
12.5 mg in 2014). Depression occurring concomitantly with
parkinsonism was treated intermittently with nortriptyline,
mirtazapine, paroxetine, nefazodone, and duloxetine. The patient
has a family history of paranoid schizophrenia (brother) and
alcoholism. At present, she is cognitively normal (Mini-Mental
Status Exam score of 27, Montreal Cognitive Assessment score of
28) and has no evidence of changes in memory.
The patient’s current medications as of October 2016 are
summarized in Table 1, categorized as “parkinsonism,” “psychiatric,” and “pain.” Her prescribed levodopa equivalent daily
dose is 650 mg, and she currently takes only levodopa (i.e., no
agonists or MAOB inhibitors). Frequent revision of medication
schedules, particularly following DBS, was a major part of her
management as the patient experienced constant debilitating
pain, frequent on- and off-period dystonia, and occasional
hallucinations. Motor benefit from levodopa (taken every 3 h
from 6 a.m. to 6 p.m. and CR at 9 p.m.) appeared in 30 min,
and lasted until 30–45 min prior to her next dose. The UPDRS
was administered 53 min after a regular dose of carbidopa/
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Table 1 | Current medications.
Medication

Parkinsonism

Psychiatric

Pain

Total daily
dose (mg)

Sinemet (carbidopa–levodopa)
Sinemet (carbidopa–levodopa)

150/600
25/100

Sinemet (carbidopa–levodopa)

50/200

Cymbalta (duloxetine)
Dextroamphetamine Sulfate
Mirtazapine
Acetaminophen
Baclofen

90
40
30
325
50

Gabapentin

3,600

Ibuprofen

2,400

Comments

1 tablet 4×/day,
as needed
1 tablet at
bedtime

As needed
10 mg 3×/day,
20 mg at bedtime
Additional 300 mg
as needed

levodopa during her October 2016 visit. The summary scores
are as follows: Part I: 3/16, Part II: 25/52, Part III: 64.5/108, and
Part IV: 4/23. For subscale III (motor), the patient has severe
bradykinesia and hypokinesia, hypophonia, and cannot rise
from her motorized chair without assistance. DBS settings were
last adjusted in January of 2015. Neither medication nor DBS
therapies currently provide sufficient relief for this patient’s
apparent task-specific upper-limb freezing during navigation,
though she reports worse and more frequent episodes during
off-medication periods.

DISCUSSION
Freezing is a complex and poorly understood feature of PD. The
pathophysiological and behavioral mechanisms associated with
freezing likely involve motor, cognitive, and sensory factors (20).
How these factors interact is still not fully understood and, as a
result, the current array of treatment approaches for freezing do
not provide sufficient long-term benefit (21). In this report, we
describe a novel case of a patient who previously experienced gait
freezing, and while now non-ambulatory, experiences episodes
in the upper limb that appear to be freezes when navigating
her wheelchair in specific situations that also commonly elicit
FOG. The circumstances and sensations during these episodes as
reported by the patient are similar to those experienced during
previous gait freezing. To our knowledge, this is one of the first
reports of apparent freezing of another part of the body during
a navigation-related task (i.e., steering a wheelchair). Systematic
studies of upper-limb freezing manipulated the spatiotemporal
components of the task to induce freezing (12–14); however, it
was not clear if these participants also experienced upper-limb
freezing during other tasks or in specific environments (such as
when passing through narrow spaces).
While the motor demands differ between walking and
navigating a wheelchair, sensory aspects such as optic flow
are similar. One current hypothesis is that freezing is due to
perceptual impairments related to visuomotor integration
of one’s body within the environment (17). Evidence for this
comes from patient reports as well as experiments examining
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how people with PD walk through spaces with varying widths,
such as doorways (22, 23). The patient reported that her freezing
was worse when entering/exiting elevators and when finding a
seat in the dining hall. Both situations challenge spatial judgment, and navigating in the dining hall was also emotionally
taxing for this particular patient. In addition, the cognitive and
emotional demands associated with these scenarios are similar
in both walking and using a wheelchair. Complex tasks can
exacerbate freezing (24), and fear related to prior freezing events
may increase anxiety and also contribute to freezing (25). This
patient has a history of mood disorder that may contribute to
emotion-related freezing triggers. Since cognitive-motor overload is also a plausible mechanism for freezing behavior (18),
cognitive interference may play a role in this case as it does in
other types of freezing. Though we saw no evidence of cognitive impairment in this individual, increasing cognitive load
has been shown to trigger freezing episodes in people with PD
who experience freezing, regardless of cognitive status (3, 26).
As a result, cognitive-motor interference may contribute to this
phenomenon. Overall, these hypotheses suggest a more general
mechanism that could apply to both FOG and upper-limb freezing during navigation, even though these two tasks have very
different motor demands.
We cannot rule out other explanations for the phenomenon
described in this case. Dystonia is a common side effect of dopaminergic treatment, usually occurring in the off-period (27).
The patient experienced previous dystonia in the lower limbs
during both on- and off-medication periods. The interruption
in her intended upper-limb movements could also potentially
be attributed to a form of dystonia. However, this is unlikely
because the patient’s previous dystonia was generalized and not
associated with certain tasks or situations, whereas the current
apparent freezing occurs only in the upper limb involved in
wheelchair navigation and only during specific situations. More
directly, dystonic posturing and pain were absent during the
episodes, and finger torsion or deviation was not observed upon
examination. Further, the patient did not report focal muscle
tension during these episodes of suspected freezing while using
the wheelchair. Recordings of muscle activity during upper-limb
freezing episodes were not able to be collected for this patient.
However, in future cases of suspected task-specific upper-limb
freezing, this may help distinguish between dystonia, which is
characterized by sustained agonist/antagonist co-contraction
(28), and freezing, which is typically accompanied by inappropriate timing of agonist/antagonist muscle pairs (3). General but
severe bradykinesia could feasibly contribute to the interruption
of her upper-limb movements as well. On the UPDRS III, the
patient scored a 4 on body bradykinesia and hypokineisa, and
a 3 or 4 on finger tapping, hand movements, and leg agility.
However, the duration of the episodes are too long to be purely
bradykinetic in nature, and the patient is able to volitionally
break the motor arrests herself in most cases, similar to what is
seen in FOG.
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This phenomenon of apparent upper-limb freezing is also
unique from typical episodes of lower limb or gait freezing.
For example, the maximal duration of the episodes reported
by the patient is atypically long compared to most reports of
FOG. Most FOG episodes last less than 10 s and rarely last
more than 30 s before movement is regained (19). However,
episodes observed within the clinic were all within the typical
reported range. The lack of arm trembling concurrent with the
episode is also uncharacteristic of FOG. However, there are
numerous reports of upper-limb freezing episodes described
as a cessation of movement in one or more hand that are not
accompanied by trembling (29–32). Further, striking similarities between this phenomenon of apparent upper-limb freezing and FOG include the identifiable environmental triggers
(crowded spaces, passageways) and the ability to interrupt the
episodes.

CONCLUSION
Overall, unique cases such as this highlight the need to consider
freezing as a problem affecting the entire sensorimotor system
and emphasize the need for clinicians and researchers to develop
new treatments for non-gait freezing.
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